Microbiome Changes in Travelers to Tropical Destinations
NCT02295254 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-10-04
Summary
The human gut contain a wide range of microorganisms creating the gut microbiome. The microbiome has great impact on metabolic and immunologic processes and responses. Travelers who travel to tropical destinations where the intestinal infection risk is high are prone to microbiome changes. During the current study the travelers will give feces specimen before and after the travel and their microbiome will be analyzed.
Conditions
- Intestinal Diseases
Interventions
- OTHER
-
feces sample
The travelers will give feces sample before and after the travel. The sample microorganisms will be analyzed.
Sponsors & Collaborators
-
Weizmann Institute of Science
collaborator OTHER -
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Eli Schwartz, MD, DTMH · [email protected]
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2018-09-30
- Completion
- 2019-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolome and Microbiomic in Fecal Samples
NCT00938028 ·Status: COMPLETED
-
Clinical Efficacy and Safety of Fecal Microbiota Transplantation
NCT04900051 ·Status: UNKNOWN
-
Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
NCT00979056 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization
NCT03391674 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Transplantation in Patients Colonic Diverticulitis
NCT06254625 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota
NCT02534272 ·Status: TERMINATED
-
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
NCT02498301 ·Status: COMPLETED ·Phase: NA
-
Autologous Fecal Therapy
NCT02046525 ·Status: COMPLETED ·Phase: PHASE2
-
Profiling Fecal Samples for Selection of Donors of Feces
NCT04078581 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Microbiota Transplant National Registry
NCT03325855 ·Status: RECRUITING
-
Intestinal Microbiome and Chemotherapy
NCT02875249 ·Status: COMPLETED
-
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
NCT02326636 ·Status: COMPLETED
-
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Fecal Microbiome Transplant
NCT02636517 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch
NCT01067781 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
NCT02801656 ·Status: WITHDRAWN ·Phase: PHASE3
-
Controlled Human Infection Model Challenge/Rechallenge
NCT04992520 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
NCT07106580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
NCT01099111 ·Status: COMPLETED
-
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
NCT03621657 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Eradication of CRE
NCT03167398 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years
NCT02561195 ·Status: COMPLETED ·Phase: PHASE2
-
Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
NCT06370884 ·Status: RECRUITING ·Phase: PHASE1